Renee Carolyn Prins, M.D.

NPI 1639381346ActiveIndividual· Internal Medicine, Hematology & Oncology· Salem, OR

Internal Medicine, Hematology & Oncology (M.D.) in Salem, Oregon, trained at Loma Linda University School of Medicine (class of 2006). Their prescriptions cost Medicare Part D more than their services did: $3,627,027 for 2,503 claims, against $2,127,794 paid for services in 2024. Astellas Pharma US Inc was the largest of 10 companies reporting payments in 2025, $648.11 in all, mostly education.

Overview

NPI	1639381346
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	May 4, 2007
Last updated in NPPES	Jun 8, 2023
Certified by provider	Jun 8, 2023

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Hematology & Oncology Primary	207RH0003X	MD29075	OR
Internal Medicine	207R00000X	MD29075	OR

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hematology/Oncology (OR)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	420
Services billed	103,454 across 163 procedure codes
Paid by Medicare	$2,127,794

Part D prescriptions in 2024

Prescriptions (claims)	2,503 · 3,979 30-day fills
Patients	277
Total drug cost	$3,627,027
Generic share	81% of claims

Medicare sources and data years

Education and affiliations

Medical school	Loma Linda University School of Medicine
Graduation year	2006
Medicare specialty	Hematology/Oncology
Secondary specialties	Hematology, Medical Oncology